METLIFE INC
Historical Data
View all| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jul 3, 2026 | $2.16 | $2.22 | $2.11 | $2.18 | 18.14M |
| Jul 2, 2026 | $2.23 | $2.40 | $2.11 | $2.16 | 11.59M |
| Jul 1, 2026 | $2.33 | $2.35 | $2.19 | $2.23 | 11.91M |
| Jun 30, 2026 | $2.39 | $2.40 | $2.30 | $2.33 | 12.02M |
| Jun 29, 2026 | $2.39 | $2.41 | $2.37 | $2.39 | 25.73M |
| Jun 28, 2026 | $2.23 | $2.60 | $2.10 | $2.39 | 26.41M |
| Jun 27, 2026 | $2.19 | $2.27 | $2.14 | $2.23 | 25.38M |
| Jun 26, 2026 | $2.10 | $2.29 | $2.02 | $2.19 | 24.85M |
Company Overview
METLIFE INC operates in the utilities space within the Utilities sector. The company generates the majority of its revenue from operating momentum, and has built a durable competitive position through scale, brand, and continued reinvestment. It serves customers globally and is headquartered in the United States. Reported figures on this page are generated for demonstration and are not investment advice.
Leadership
Board 13 · Independent 12 of 13| Date | Firm | Target | Rating |
|---|---|---|---|
| Jun 28 | Morgan Stanley | $2.67 | Hold |
| Jun 21 | Melius Research | $3.89 | Buy |
| Jun 20 | Piper Sandler | $2.19 | Overweight |
| Jun 15 | Needham | — | Reduce |
| Jun 4 | KeyBanc | $3.88 | Buy |
| May 13 | Citi | $3.16 | Hold |
Politician Trades
View allWhat's Happening Right Now
- Sep 20, 2026 · Analyst ↗ — Analysts maintain a consensus 'Moderate Buy' rating on MetLife shares.
- Sep 16, 2026 · Institutional ↗ — Bank of America Corp DE acquired 5,382,630 shares of MetLife.
- Sep 18, 2026 · Institutional ↗ — Nykredit A/S acquired 2,111,310 shares of MetLife.
- Sep 15, 2026 · Institutional ↗ — California State Teachers Retirement System sold shares of MetLife.
- Sep 18, 2026 · Insider/Affiliate ↗ — A MetLife affiliate lined up a September stock sale, part of several disclosed separate-account share sales.
Snapshot
MetLife reported FY2025 revenue of $2.44B, up 8.6% year-over-year, with net income of $3.38B representing a 4.4% margin. The company generated $17.09B in operating cash flow, which equaled free cash flow, indicating minimal capital expenditure needs relative to cash generation. MetLife holds $22.03B in cash and equivalents against $24.05B in total debt, leaving a relatively modest net debt position. Recent activity has centered on routine institutional buying and selling and analyst sentiment rather than major corporate events.
Bottom Line
MetLife's substantial free cash flow generation ($17.09B) relative to its revenue base and a well-covered debt load ($24.05B against $22.03B cash) point to solid balance sheet flexibility. However, the thin 4.4% net margin on reported revenue suggests limited near-term profitability upside from current top-line growth alone. Recent news flow is dominated by institutional position changes and a moderate analyst consensus rather than transformative catalysts, implying the stock's near-term trajectory may hinge more on macro/rate conditions than company-specific news.